Tag: INDIA
Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation
Bharat Technology is set to organise BT-PHARMACON 2K26, an ANRF-sponsored national conference on September 26–27, 2026, at the Eastern Zonal Cultural Centre (EZCC), Kolkata.
The conference will...
Johnson & Johnson Presents New Clinical Data Across Bipolar Mania, Depression and Schizophrenia
Johnson & Johnson announced the presentation of comprehensive new clinical and real-world data across its industry-leading neuropsychiatry portfolio at Psych Congress 2026. The findings...
Government Panel Recommends Keeping Doorstep Medicine Delivery Rule with Stricter Enforcement
A government sub-committee has recommended retaining the doorstep medicine delivery notification 2020, despite objections from The All-India Organisation of Chemists and Druggists (AIOCD), which argued the rule was...
Supreme Court of India Refuses to Quash CBI Complaint Against Sanofi India in BARC Procurement Case
The Supreme Court dismissed an appeal filed by Sanofi India Limited, refusing to quash criminal proceedings arising from a CBI chargesheet. The court ruled that...
Novartis India’s Strategic Hypertension Play: ₹1,250 Crore for Pfizer’s Minipress Takeover
ChrysCapital-backed Novartis India has acquired Pfizer's Minipress and Minipres trademarks for Rs 1,250 crore, marking a significant expansion of its cardiovascular portfolio. The acquisition, approved by Novartis...
Lupin Receives U.S. FDA Approval for Modafinil Tablets USP Across 100 mg and 200 mg Strengths
Lupin Limited announced that it has received final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application...
